Advertisement

If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?

If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?

Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.